Investigating the novel role of acetylation in cardiac mitochondrial bioenergetics and function in the aging heart
研究乙酰化在心脏线粒体生物能学和衰老心脏功能中的新作用
基本信息
- 批准号:9890081
- 负责人:
- 金额:$ 17.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-08 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAcetyltransferaseAddressAgeAgingAnimal ModelAnimalsBioenergeticsBiological AssayBiological ProcessBiologyCardiacCardiac MyocytesCoenzyme ACoupledDataDeacetylaseDevelopmentDevelopment PlansDietDiseaseEnergy MetabolismEnergy SupplyEnvironmentEnzymesFunctional disorderFutureGenerationsGeneticGoalsHeartHumanIn VitroKnowledgeLeadLong-Chain-Acyl-CoA DehydrogenaseLysineMass Spectrum AnalysisMediatingMentorshipMetabolicMitochondriaModelingMolecularMusMyocardial dysfunctionObese MiceObesityOxidoreductasePathogenesisPeptidesPopulation GrowthPost-Translational Protein ProcessingProcessProtein AcetylationProteinsProteomicsRegulationResearchResearch PersonnelResearch ProposalsResolutionResourcesRoleSiteStressSystemTestingTissuesUniversitiesWorkage relatedagedaging populationbasebiochemical toolscareer developmenteconomic impactenzyme activityenzyme substratefatty acid oxidationflexibilityhealth economicshealthy agingheart functionimprovedin vivoinsightlong chain fatty acidmiddle agemitochondrial dysfunctionmitochondrial metabolismnew therapeutic targetnovelnovel therapeuticsoxidationpreventresearch studytherapy outcometraining opportunity
项目摘要
Cardiac mitochondrial dysfunction is central to the pathogenesis of aging and many age related diseases.
Mitochondria supply the bioenergetic capacity for cardiac contractile function through oxidation of fuel
substrates and a complete control of this system is indispensable to maintain cardiac efficiency. Specifically,
the role of Hydroxyacyl-CoA Dehydrogenase (HADHA) and Long Chain Acyl-CoA Dehydrogenase (LCAD) in
catalyzing the oxidation of long chain fatty acids in the heart is well studied and their dysfunction is associated
with decreased fatty acid oxidation (FAO) and cardiac energy depletion. However, studies focused on
understanding the cellular mechanisms that regulate these key mitochondrial energy substrate enzymes in the
aging heart are scarce. In a recent study, we described that increased acetylation increases the activities of
LCAD and HADHA in diet induced obesity, which was mediated by changes in the expression of mitochondrial
acetyltransferase GCN5L1 and deacetylase SIRT3. In the aging heart, we observe increased GCN5L1 and
decreased SIRT3 expression resulting in an increased acetylation status of HADHA and LCAD. Based on
these observations, we hypothesize that GCN5L1 and SIRT3 control HADHA and LCAD acetylation, and that
dysregulation of this mechanism in aging contributes to reduced mitochondrial bioenergetics and
cardiomyocyte energy depletion. To test our central hypothesis, we propose the following aims: 1. We will
investigate how acetylation regulates the activity of HADHA and LCAD in young, middle aged and old mouse
hearts. Using high resolution mass spectrometry based proteomics; we will identify acetylation sites, relative
quantification and assess their impact in key biological processes and enzymatic functions. 2. We will
investigate the mechanisms associated with regulation of HADHA and LCAD activity in young, middle aged
and old mouse hearts. We will use novel GCN5L1 and SIRT3 cardiac KO animal to delineate the molecular
mechanisms underlying changes in HADHA and LCAD acetylation in aging process. 3. We will investigate how
changes in fatty acid oxidation protein acetylation impacts mitochondrial bioenergetics and cardiac contractile
function in aging heart. The long term goal of this study is to understand the regulatory role of cardiac
mitochondrial acetylation in human aging and age related diseases. Our results will improve our understanding
of acetylation mediated regulation of FAO enzymes in aging mitochondrial biology and provide novel insights
on regulation of fuel substrate usage in the aging heart and their contribution towards improving mitochondrial
and cardiac function with age.
心脏线粒体功能障碍是衰老和许多年龄相关疾病的发病机制的核心。
线粒体通过氧化燃料为心脏收缩功能提供生物能量
基质和该系统的完全控制对于维持心脏效率是必不可少的。具体地说,
羟酰辅酶A脱氢酶(HADHA)和长链酰辅酶A脱氢酶(LCAD)在
心脏中催化长链脂肪酸氧化的作用已被充分研究,
脂肪酸氧化(FAO)和心脏能量消耗减少。然而,研究集中在
了解调节这些关键线粒体能量底物酶的细胞机制,
衰老的心脏是稀缺的。在最近的一项研究中,我们描述了乙酰化的增加增加了
LCAD和HADHA在饮食诱导的肥胖中的作用,这是由线粒体表达的变化介导的。
乙酰转移酶GCN 5L1和脱乙酰酶SIRT 3。在衰老的心脏中,我们观察到GCN 5L1增加,
SIRT3表达降低导致HADHA和LCAD的乙酰化状态增加。基于
根据这些观察,我们假设GCN 5L1和SIRT 3控制HADHA和LCAD乙酰化,
这种机制在衰老中的失调有助于降低线粒体生物能量学,
心肌细胞能量耗竭为了检验我们的中心假设,我们提出了以下目标:1。我们将
探讨乙酰化对青年、中年和老年小鼠HADHA和LCAD活性的调节作用
心中使用基于高分辨率质谱的蛋白质组学,我们将确定乙酰化位点,相对
量化和评估它们在关键生物过程和酶功能中的影响。2.我们将
探讨青年、中年人HADHA和LCAD活性调节的相关机制,
还有老鼠的心脏我们将使用新的GCN 5L1和SIRT 3心脏KO动物来描绘分子水平,
衰老过程中HADHA和LCAD乙酰化变化的潜在机制。3.我们将调查如何
脂肪酸氧化蛋白乙酰化的变化影响线粒体生物能量学和心肌收缩
衰老心脏的功能。这项研究的长期目标是了解心脏的调节作用,
线粒体乙酰化在人类衰老和年龄相关疾病中的作用。我们的研究结果将增进我们对
乙酰化介导的FAO酶在衰老线粒体生物学的调节,并提供新的见解
调节衰老心脏中燃料底物的使用及其对改善线粒体的贡献
和心脏功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dharendra Thapa其他文献
Dharendra Thapa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dharendra Thapa', 18)}}的其他基金
Investigating the novel role of acetylation in cardiac mitochondrial bioenergetics and function in the aging heart
研究乙酰化在心脏线粒体生物能学和衰老心脏功能中的新作用
- 批准号:
10480897 - 财政年份:2020
- 资助金额:
$ 17.3万 - 项目类别:
Investigating the novel role of acetylation in cardiac mitochondrial bioenergetics and function in the aging heart
研究乙酰化在心脏线粒体生物能学和衰老心脏功能中的新作用
- 批准号:
10083227 - 财政年份:2020
- 资助金额:
$ 17.3万 - 项目类别:
Investigating the novel role of acetylation in cardiac mitochondrial bioenergetics and function in the aging heart
研究乙酰化在心脏线粒体生物能学和衰老心脏功能中的新作用
- 批准号:
10471062 - 财政年份:2020
- 资助金额:
$ 17.3万 - 项目类别:
Investigating the novel role of acetylation in cardiac mitochondrial bioenergetics and function in the aging heart
研究乙酰化在心脏线粒体生物能学和衰老心脏功能中的新作用
- 批准号:
10683270 - 财政年份:2020
- 资助金额:
$ 17.3万 - 项目类别:
相似海外基金
Dissecting out differential molecular phenotypes across Lysine(K) AcetylTransferase mutations in mouse development
剖析小鼠发育过程中赖氨酸(K)乙酰转移酶突变的差异分子表型
- 批准号:
10727966 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Targeting lysine acetyltransferase MOF/KAT8 in lung cancer
靶向赖氨酸乙酰转移酶 MOF/KAT8 在肺癌中的作用
- 批准号:
10601761 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Defining the cell-type specific role of histone acetyltransferase KAT2a in nucleus accumbens D1 medium spiny neurons as a driver of cocaine use disorder
定义组蛋白乙酰转移酶 KAT2a 在伏隔核 D1 中型多棘神经元中作为可卡因使用障碍驱动因素的细胞类型特异性作用
- 批准号:
10679238 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Roles of lysine acetyltransferase 6 complexes in cerebral development and neurodevelopmental disorders
赖氨酸乙酰转移酶 6 复合物在大脑发育和神经发育障碍中的作用
- 批准号:
479754 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Operating Grants
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10344246 - 财政年份:2022
- 资助金额:
$ 17.3万 - 项目类别:
Examination of the Histone Acetyltransferase CBP in the Remodelling of Thermogenic Adipose Tissues
组蛋白乙酰转移酶 CBP 在生热脂肪组织重塑中的检测
- 批准号:
486467 - 财政年份:2022
- 资助金额:
$ 17.3万 - 项目类别:
Studentship Programs
Nuclear activity of carnitine acetyltransferase
肉毒碱乙酰转移酶的核活性
- 批准号:
RGPIN-2018-06089 - 财政年份:2022
- 资助金额:
$ 17.3万 - 项目类别:
Discovery Grants Program - Individual
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10627744 - 财政年份:2022
- 资助金额:
$ 17.3万 - 项目类别:
Characterizing the role of the NuA3 histone acetyltransferase complex during transcription
表征 NuA3 组蛋白乙酰转移酶复合物在转录过程中的作用
- 批准号:
557615-2021 - 财政年份:2022
- 资助金额:
$ 17.3万 - 项目类别:
Postdoctoral Fellowships
Structural and functional studies of histone acetyltransferase complexes
组蛋白乙酰转移酶复合物的结构和功能研究
- 批准号:
RGPIN-2018-03951 - 财政年份:2022
- 资助金额:
$ 17.3万 - 项目类别:
Discovery Grants Program - Individual